GENNEX LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of GENNEX LABORATORIES have increased by 7.17% YoY .
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 6.25 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GENNEX LABORATORIES Last 5 Annual Financial Results
[BOM: 531739]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹66 Cr | ₹61 Cr | ₹60 Cr | ₹56 Cr | ₹56 Cr |
| Expenses | ₹61 Cr | ₹56 Cr | ₹53 Cr | ₹52 Cr | ₹52 Cr |
| Operating Profit (Excl OI) | ₹4.69 Cr | ₹5.38 Cr | ₹6.53 Cr | ₹3.25 Cr | ₹4.02 Cr |
| Other Income | ₹3.95 Cr | ₹1.38 Cr | ₹0.52 Cr | ₹0.95 Cr | ₹0.78 Cr |
| Interest | ₹1.35 Cr | ₹0.88 Cr | ₹0.74 Cr | ₹0.75 Cr | ₹0.79 Cr |
| Depreciation | ₹0.92 Cr | ₹0.79 Cr | ₹0.88 Cr | ₹1.01 Cr | ₹0.99 Cr |
| Profit Before Tax | ₹6.37 Cr | ₹5.09 Cr | ₹5.06 Cr | ₹2.55 Cr | ₹3.03 Cr |
| Profit After Tax | ₹4.92 Cr | ₹3.92 Cr | ₹4.04 Cr | ₹1.86 Cr | ₹2.22 Cr |
| Consolidated Net Profit | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr | ₹1.86 Cr | ₹2.22 Cr |
| Earnings Per Share (Rs) | ₹0.34 | ₹0.32 | ₹0.32 | ₹0.15 | ₹0.18 |
| PAT Margin (%) | 6.85 | 6.01 | 6.34 | 3.10 | 3.70 |
| ROE(%) | 8.55 | 9.39 | 10.71 | 5.34 | 6.77 |
| ROCE(%) | 10.84 | 11.82 | 13.24 | 8.36 | 10.52 |
| Total Debt/Equity(x) | 0.24 | 0.23 | 0.19 | 0.14 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 368.2 Cr |
| Revenue (TTM) | : | ₹ 70.7 Cr |
| Net Profit(TTM) | : | ₹ 9.8 Cr |
| EPS (TTM) | : | ₹ 0.4 |
| P/E (TTM) | : | 37.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENNEX LABORATORIES | -1.4% | -6.5% | 178.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
| CIPLA | 4.1% | -4.8% | 55.6% |
| DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
| ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
| DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
| MANKIND PHARMA | 1.3% | 7% | NA |
| TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
| LUPIN | 0.6% | 0.5% | 127.2% |
GENNEX LABORATORIES Revenues
[BOM: 531739]
| Y-o-Y | 7.17 % |
| 5 Yr CAGR | 4.13 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹66 Cr | 7.17 | |
| Mar2022 | ₹61 Cr | 2.62 | |
| Mar2021 | ₹60 Cr | 7.25 | |
| Mar2020 | ₹56 Cr | -0.33 | |
| Mar2019 | ₹56 Cr | - | |
GENNEX LABORATORIES Operating Profit
[BOM: 531739]
| Y-o-Y | -12.74 % |
| 5 Yr CAGR | 3.93 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹4.69 Cr | -12.74 | |
| Mar2022 | ₹5.38 Cr | -17.68 | |
| Mar2021 | ₹6.53 Cr | 101.20 | |
| Mar2020 | ₹3.25 Cr | -19.29 | |
| Mar2019 | ₹4.02 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -18.66 % |
| 5 Yr CAGR | -0.21 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 7.15% | -18.66 | |
| Mar2022 | 8.79% | -19.73 | |
| Mar2021 | 10.95% | 87.50 | |
| Mar2020 | 5.84% | -19.00 | |
| Mar2019 | 7.21% | - | |
GENNEX LABORATORIES Profit After Tax
[BOM: 531739]
| Y-o-Y | 50.89 % |
| 5 Yr CAGR | 29.23 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹6.19 Cr | 50.89 | |
| Mar2022 | ₹4.11 Cr | 1.66 | |
| Mar2021 | ₹4.04 Cr | 117.56 | |
| Mar2020 | ₹1.86 Cr | -16.43 | |
| Mar2019 | ₹2.22 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 13.98 % |
| 5 Yr CAGR | 16.65 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 6.85 % | 13.98 | |
| Mar2022 | 6.01 % | -5.21 | |
| Mar2021 | 6.34 % | 104.52 | |
| Mar2020 | 3.1 % | -16.22 | |
| Mar2019 | 3.7 % | - | |
GENNEX LABORATORIES Earnings Per Share (EPS)
[BOM: 531739]
| Y-o-Y | 6.25 % |
| 5 Yr CAGR | 17.23 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹0.34 | 6.25 | |
| Mar2022 | ₹0.32 | 0.00 | |
| Mar2021 | ₹0.32 | 113.33 | |
| Mar2020 | ₹0.15 | -16.67 | |
| Mar2019 | ₹0.18 | - | |
GENNEX LABORATORIES Return on Capital Employed (ROCE)
[BOM: 531739]
| Y-o-Y | -8.29 % |
| 5 Yr CAGR | 0.75 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 10.84% | -8.29 | |
| Mar2022 | 11.82% | -10.73 | |
| Mar2021 | 13.24% | 58.37 | |
| Mar2020 | 8.36% | -20.53 | |
| Mar2019 | 10.52% | - | |
GENNEX LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹16.1 |
| Current MarketCap | : | ₹ 368.2 Cr |
| Updated EOD on | : | Apr 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -1.4% |
-6.5% |
178.6% |
| SENSEX | 0.9% |
1.5% |
23.6% |
GENNEX LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about GENNEX LABORATORIES Financials
How the annual revenues of GENNEX LABORATORIES have changed ?
The Revenues of GENNEX LABORATORIES have increased by 7.17% YoY .
How the Earnings per Share (EPS) of GENNEX LABORATORIES have changed?
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 6.25 % YoY .
Check out Intrinsic Value of Peers of GENNEX LABORATORIES
Compare Stock Analytics of Peers of GENNEX LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
